Pharmacology of agents used in bone marrow transplant conditioning regimens.
Wiebe
V J
VJ
University of Texas Health Science Center, San Antonio.
Smith
B R
BR
DeGregorio
M W
MW
Rappeport
J M
JM
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D016026:Bone Marrow Transplantation; D002066:Busulfan / Q000031:analogs & derivatives / Q000494:pharmacology; D002330:Carmustine / Q000494:pharmacology; D006410:Hematopoiesis / Q000187:drug effects* / Q000528:radiation effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D008558:Melphalan / Q000494:pharmacology; D014916:Whole-Body Irradiation
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; C002037:dimethylmyleran; D002066:Busulfan; D008558:Melphalan; D002330:Carmustine